Prescriber adherence to treatment guidelines for monoclonal antibodies against Calcitonin Gene-Related Peptide in migraine prophylaxis – a register-based cohort study

Abstract Background Calcitonin Gene-Related Peptide targeting monoclonal antibodies (CGRP mAbs) were introduced for migraine prophylaxis in Sweden through the National Joint Introduction process to ensure an equal, cost-effective, and appropriate national use. This study aimed to assess prescriber a...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Sofia Nordenmalm, Rickard E. Malmström, Sara Freyland, A. Ingela M Nilsson Remahl, Karin Wirdefeldt, Isabella Ekheden
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2026-03-01
coleção:	The Journal of Headache and Pain
Assuntos:	Migraine disorders Calcitonin gene-related peptide Calcitonin gene-related peptide receptor antagonists Antibodies, monoclonal Managed care programs Practice guidelines as topic
Acesso em linha:	https://doi.org/10.1186/s10194-026-02322-1
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!